Clinical TrialsSearch results
Number of results: 223
Recruiting
- Clinical study on oral squamous cell carcinoma patients with malnutrition
- Oral squamous cell carcinoma
- Suzuki Hajime
- 2023-08-29
Recruiting
- Phase II trial of Survivin-responsive oncolytic adenovirus (Surv.m-CRA-1) by repeated intratumoral injection in advanced bone tumor patients.
- Advanced primary malignant bone tumor
- Nagano Satoshi
- 2022-01-22
Recruiting
- A Phase I/II Study of RO4893594-PDS in Japanese Patients with Neovascular Age-Related Macular Degeneration and Japanese Patients with Diabetic Macular Edema
- Neovascular age-related macular degeneration (nAMD) and with diabetic macular edema (DME)
- Ogura Yuichiro
- 2021-10-02
Other
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K delta Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis
- Myelofibrosis, (Primary, Post Essential Thrombocythemia, Post Polycythemia Vera) Myelofibrosis
- Ueda Eiji
- 2021-03-17
Other
- Clinical evaluation of matrix metalloproteinases as early diagnostic markers of peritoneal deterioration and encapsulating peritoneal sclerosis.
- encapsulating peritoneal sclerosis (EPS)/ sclerosing encapsulating peritonitis(SEP)
- Division of Nephrology, Department of Medicine, Jichi Medical University
- 2013-04-30
Recruiting
- A psychosomatic study for the functions of ghrelin.
- Eating disorder
- Kagoshima University Graduate School of Medical and Dental Sciences
- 2010-03-31
Other
- Randomized clinical trial about the period of antimicrobial prophylaxis administration in hepatocellular carcinoma surgery
- Patients undergoing elective hepatocellular carcinoma surgery
- Randomized clinical trial committee, Japan Society for Surgical Infection
- 2009-12-09
Other
- Effect of middle ear pressure change on clincal symptoms in patients with endolymphatic hydrops of the inner ear
- endolymphatic hydrops
- Dept. of Otolaryngology, University of Toyama
- 2009-10-01
Other
- A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-10
Other
- A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-01